Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Corrigendum to "m6A-related genes ALKBH5 and RBMX as prognostic and progression biomarkers in Chinese oral squamous cell carcinoma patients" [Archives of Oral Biology 170 (2024) 106149]. | Arch Oral Biol | 2025 | 40315717 | PubTator, text mining | PubMed |
| Inhibition of ALKBH5 demethylase of m6A pathway potentiates HIV-1 reactivation from latency. | Virol J | 2025 | 40296171 | PubTator, text mining | PubMed |
| Aberrant overexpression of m6A writer and reader genes in pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL). | Transl Oncol | 2025 | 40288000 | PubTator, text mining | PubMed |
| m6A-Mediated TMCO3 Promotes Hepatocellular Carcinoma Progression by Facilitating the Membrane Translocation and Activation of AKT. | Adv Sci (Weinh) | 2025 | 40285646 | PubTator, text mining | PubMed |
| Insight into mechanism of ALKBH5-mediated N6-methyladenosine (m6A) regulating porcine epidemic diarrhea virus infection in IPEC-J2 cells. | Int J Biol Macromol | 2025 | 40280045 | PubTator, text mining | PubMed |
| Epigenetics of maternal-fetal interface immune microenvironment and placental related pregnancy complications. | Front Immunol | 2025 | 40248704 | PubTator, text mining | PubMed |
| Deciphering single-cell landscape unravels cell-type-specific functional roles of RNA m6A modification in atherosclerosis. | Theranostics | 2025 | 40225569 | PubTator, text mining | PubMed |
| DeepHeteroCDA: circRNA-drug sensitivity associations prediction via multi-scale heterogeneous network and graph attention mechanism. | Brief Bioinform | 2025 | 40223811 | PubTator, text mining | PubMed |
| The microbiota-m6A-metabolism axis: Implications for therapeutic strategies in gastrointestinal cancers. | Biochim Biophys Acta Rev Cancer | 2025 | 40222422 | PubTator, text mining | PubMed |
| Expression pattern of RNA demethylase ALKBH5 in fetal and adult human testis. | Tissue Cell | 2025 | 40222158 | PubTator, text mining | PubMed |
| Cell-Type-Specific mRNA N6-Methyladenosine Landscape and Regulatory Mechanisms Underlying Immune Dysregulation of Sleep-Deprived. | J Pineal Res | 2025 | 40214141 | PubTator, text mining | PubMed |
| m6A demethylase ALKBH5 reduces ferroptosis in diabetic retinopathy through the m6A-YTHDF1-ACSL4 axis. | Diabet Med | 2025 | 40210448 | PubTator, text mining | PubMed |
| Follicle-stimulating hormone promotes EndMT in endothelial cells by upregulating ALKBH5 expression. | Cell Mol Biol Lett | 2025 | 40186131 | PubTator, text mining | PubMed |
| RNA modifications in the tumor microenvironment: insights into the cancer-immunity cycle and beyond. | Exp Hematol Oncol | 2025 | 40176140 | PubTator, text mining | PubMed |
| ALKBH5-mediated m6A regulates the alternative splicing events of SRSF10 in ovarian cancer. | Cancer Gene Ther | 2025 | 40175608 | PubTator, text mining | PubMed |
| METTL3, an Independent Adverse Prognostic Factor for AML, Promotes the Development of AML by Modulating the PGC-1α-MAPK Pathway and PGC-1α-Antioxidant System Axis. | Cancer Med | 2025 | 40171845 | PubTator, text mining | PubMed |
| Arg-Gly-Asp engineered mesenchymal stem cells as targeted nanotherapeutics against kidney fibrosis by modulating m6A. | Acta Biomater | 2025 | 40158765 | PubTator, text mining | PubMed |
| Cigarette smoking modulates m6A modification, affecting the induction of CYP1A1 mRNA by regulating human ARNT and AHRR in A549 cells. | Toxicol Lett | 2025 | 40118351 | PubTator, text mining | PubMed |
| Diabetic kidney disease: m6A modification as a marker of disease progression and subtype classification. | Front Med (Lausanne) | 2025 | 40103797 | PubTator, text mining | PubMed |
| Insights From m6A RNA Methylation: Biomarkers for Diagnosis of Acute Myocardial Infarction. | J Inflamm Res | 2025 | 40093945 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=17